Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis
about
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesHELMINTHS AND TB IN POLYNESIA: THE IMPLICATIONS FOR HEALTH PRACTICERecombinant Mycobacterium bovis BCG as an HIV vaccine vector.Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Perspectives on clinical and preclinical testing of new tuberculosis vaccines.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsCommonly administered bacille Calmette-Guerin strains induce comparable immune response.Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms.Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine.Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.Early-shared Mycobacterium bovis bacillus Calmette-Guérin sub-strains induce Th1 cytokine production in vivo.A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells.
P2860
Q28083377-60A4C798-CD05-4582-A9D6-8C839ADDFD0CQ28476626-F9721462-B03A-47C0-8DD6-4798BC27D0D1Q29392240-B927CF81-E781-4C3C-BB72-365EE28C2DF0Q30387447-A870B318-D143-4A73-A323-E6620D3A876EQ33444699-646433DC-E28D-4975-985C-DFBAF614BB63Q33791961-F163E055-C3CF-4E80-AAC3-39F1E4B8ADFCQ34189865-75EEB359-00E4-4223-95D1-C1D17D83DFB9Q35826779-3485573A-AEC8-493A-8AAA-0DF9DA90D0EAQ36317705-5D30A470-A52D-44F2-A02D-5CC248074E0FQ36756892-EBBF86EA-E794-4366-A4F9-2C6EA62346A9Q37054583-945BE998-65E8-42DF-B878-1C2931BF010CQ37443290-F1D116E6-82A3-4E82-AB92-AEEB71CA1D87Q40985451-E529EB6A-C97F-4C17-8F6D-B806C554B5F4Q44053607-3EBFA3E7-3A24-4F5D-8808-1C8A6325F67AQ47605682-4AFEF7EF-7E2B-46F2-939A-4FB6785E3F64
P2860
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Commonly administered BCG stra ...... immunity against tuberculosis
@en
Commonly administered BCG stra ...... immunity against tuberculosis.
@nl
type
label
Commonly administered BCG stra ...... immunity against tuberculosis
@en
Commonly administered BCG stra ...... immunity against tuberculosis.
@nl
prefLabel
Commonly administered BCG stra ...... immunity against tuberculosis
@en
Commonly administered BCG stra ...... immunity against tuberculosis.
@nl
P2093
P2860
P1433
P1476
Commonly administered BCG stra ...... immunity against tuberculosis
@en
P2093
Barbara Jane Dillon
Günter Harth
Marcus A Horwitz
Sasa Maslesa-Galić
P2860
P304
P356
10.1016/J.VACCINE.2008.10.058
P407
P577
2008-11-11T00:00:00Z